Newstral
Article
jdsupra.com on 2021-04-05 20:17
PMPRB Updates: Definition of “Gap Medicine” amended, modified threshold for investigating the price of new patented medicines
Related news
- Update on amended Patented Medicines Regulationsjdsupra.com
- PMPRB releases draft Guidelines operationalizing amended Patented Medicines Regulationsjdsupra.com
- Drug pricing in Canada: Changes for the PMPRB with proposed amendments to the Patented Medicines Regulationsjdsupra.com
- Slam dunk! New basket of countries for PMPRB reporting remain, controversial amendments to Patented Medicines Regulations droppedjdsupra.com
- PMPRB adopts Amended Interim Guidance pending release of new guidelinesjdsupra.com
- PMPRB Update: Jurisdiction extends to CSPs effective June 30; coming into force of Patented Medicines Regulations and Guidelines delayed to January 2022jdsupra.com
- Discussion Guide for PMPRB Phase 2 Consultations on New Guidelines outlines proposed new framework for patented medicine price reviewjdsupra.com
- Confidential rebate reporting and new price regulatory factors of the amended Patented Medicines Regulations declared invalid by the Quebec Court of Appealjdsupra.com
- PMPRB update: Revised compliance timelines for grandfathered and gap medicines and proposed regulatory amendments directed to CSPsjdsupra.com
- Revised draft Guidelines operationalizing the Patented Medicines Regulations: notable changesjdsupra.com
- Canada releases proposed amendments to Regulations governing patented medicines pricingjdsupra.com
- Canadian Institute for Health Information (CIHI) and Patented Medicine Prices Review Board (PMPRB) report upward trend of high-cost drugsjdsupra.com
- Federal Court of Appeal dismisses appeal challenging amended basket of comparator countries in PMPRB Regulationsjdsupra.com
- Quebec Court finds price and revenue calculation provisions of amended PMPRB Regulations unconstitutionaljdsupra.com
- 2021 PMPRB Annual Reportjdsupra.com
- PMPRB proposes to modify Guidelines definition of "gap medicine" to include medicines sold by July 1, 2021jdsupra.com
- Canada releases final amendments to Patented Medicines Pricing Regulations; in force July 1, 2020jdsupra.com
- Federal Court releases decision on validity of the Amending Regulations of the Patented Medicines Regulationsjdsupra.com
- Federal Court strikes price calculation provision of amendments to Patented Medicines Regulationsjdsupra.com
- Proposed amendments to the Patented Medicines (Notice of Compliance) Regulations would expand definition of “claim for the medicinal ingredient”jdsupra.com